🇧🇷 Chrft5 in Brazil

Chrft5 (BASILIXIMAB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Chrft5 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Brazil

Frequently asked questions

Is Chrft5 approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Chrft5 in Brazil?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.